Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1988-12-19
1991-10-22
Lovering, Richard D.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
534 10, 424 9, 424DIG6, A61K 4300, C07F 500
Patent
active
050594125
ABSTRACT:
Particle emitting radionuclides, e.g. Samarium-153, have been complexed with certain macrocyclic aminophosphonic acids wherein the nitrogen and phosphorus are interconnected by an alkylene group or substituted alkylene group. These complexes have been found useful in compositions and formulations for the therapeutic treatment of calcific tumors in animals.
REFERENCES:
patent: 3965254 (1976-06-01), Tofe et al.
patent: 4017595 (1977-04-01), Subramanian et al.
patent: 4187284 (1980-02-01), Rolleston et al.
patent: 4853209 (1989-08-01), Kaplan et al.
patent: 4882142 (1989-11-01), Simon et al.
patent: 4885363 (1989-12-01), Tweedle et al.
patent: 4898724 (1990-02-01), Simon et al.
patent: 4957939 (1990-09-01), Gries et al.
patent: 4976950 (1990-12-01), Simon et al.
Inorg. Chem. 28(17), 3336-3341 (1989); Three cyclic Aminomethylenephosphonic acids.
Inorganica Chim. Acta 139, 137-139, (1987); DOTMP complexed.
J. Magn. Reson. 76, 528-533 (Feb. 1988); First use of the Dy-DOTMP complex.
Izv. Akad. Nauk. SSSR, Ser. Khim. 4, 835-843 (Apr. 1964), Trans. in Bull. Acad. Sci. USSR, Div. of the Chem. Sci 33(4), 769 (Apr. 1984); cyclic amino phosphonic acids.
Izv. Akad. Nauk. SSSR, Ser. Khim. 4, 844-849 (Apr. 1984), Trans. in Bull. Acad. Sci. USSR, Div. of the Chem. Sci. 33(4), 777 (Apr. 1984); Synthesis of DOTMP from the cyclic amine.
Teor. Eksp. Khim. 21(6), 660-669 (Nov.-Dec. 1985); A theoretical conformational analysis of DOTMP and a triazacyclic phosphonic acid.
Teor. Eksp. Khim. 22(6), 655-661 (Nov.-Dec. 1986); Theoretical molecular mechanics calculations of complex forming conformations of DOTMP.
Izv. Akad. Nauk. SSSR, Ser. Khim. 2, 413-417 (Apr. 1987); discloses the preparation of DOTMP as an intermediate in the preparation of the cyclo-dependent compounds.
Chemical Abstracts 87:179938h (1977), G. Subramanian et al.
Int. J. App. Rad. and Isotopes, vol. 14 (1963), Rosoff et al., pp. 129-135.
Garlich Joseph R.
Simon Jaime
Troutner David E.
Wilson David A.
Covert John M.
Kimble Karen L.
Lovering Richard D.
The Dow Chemical Company
LandOfFree
Macrocyclic aminophosphonic acid complexes for the treatment of does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrocyclic aminophosphonic acid complexes for the treatment of , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic aminophosphonic acid complexes for the treatment of will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-107083